<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-82S2E4DT</identifier><date>2008</date><creator>Červek, Jožica</creator><relation>documents/doc/8/URN_NBN_SI_doc-82S2E4DT_001.pdf</relation><relation>documents/doc/8/URN_NBN_SI_doc-82S2E4DT_001.txt</relation><format format_type="volume">12</format><format format_type="issue">2</format><format format_type="type">article</format><format format_type="extent">str. 135-136</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID">25341145</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-82S2E4DT</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">drug</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">opoidi</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zaprtje</subject><subject language_type_id="slv">zdravila</subject><subject language_type_id="slv">zdravljenje</subject><title>novo tarčno zdravilo, njegov pomen v paliativni oskrbi</title><title>Metilnaltreksonijev bromid</title></Record>